This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/518691-blood-clots-astrazeneca-vaccine-denmark/
The article has changed 3 times. There is an RSS feed of changes available.
Version 0 | Version 1 |
---|---|
Blood clots & one death reported in Denmark after hospital staffers take AstraZeneca vaccine | Blood clots & one death reported in Denmark after hospital staffers take AstraZeneca vaccine |
(6 months later) | |
Two hospital staffers in Denmark experienced blood clots and cerebral haemorrhaging after they were vaccinated against Covid-19 with AstraZeneca's jab. One has since died. | Two hospital staffers in Denmark experienced blood clots and cerebral haemorrhaging after they were vaccinated against Covid-19 with AstraZeneca's jab. One has since died. |
Denmark revealed on Saturday that both staffers experienced issues less than fourteen days after being vaccinated. However, details of the incidents are currently scarce. | Denmark revealed on Saturday that both staffers experienced issues less than fourteen days after being vaccinated. However, details of the incidents are currently scarce. |
The new report comes amid increasing concerns in the European Union over whether AstraZeneca's Covid-19 vaccine is linked to blood clots. | The new report comes amid increasing concerns in the European Union over whether AstraZeneca's Covid-19 vaccine is linked to blood clots. |
At least 10 cases of people in Denmark experiencing blood clots after receiving the jab were reported earlier this week, and the same issues have been reported all across Europe. However, European Union member states resumed distribution of the jabs after a temporary suspension and investigation concluded that the benefits outweighed the risk. | At least 10 cases of people in Denmark experiencing blood clots after receiving the jab were reported earlier this week, and the same issues have been reported all across Europe. However, European Union member states resumed distribution of the jabs after a temporary suspension and investigation concluded that the benefits outweighed the risk. |
Finland, on the other hand, suspended distribution of the vaccine on Friday after a further two cases of thromboembolic events were recorded in recipients. | Finland, on the other hand, suspended distribution of the vaccine on Friday after a further two cases of thromboembolic events were recorded in recipients. |
Norwegian scientists have claimed that blood clots are linked to AstraZeneca's vaccine, while French regulator HAS (Haute Autorite de Sante) has recommended that it be administered only to those over the age of 55 – citing a "possible increased risk" of blood clotting in younger people. | Norwegian scientists have claimed that blood clots are linked to AstraZeneca's vaccine, while French regulator HAS (Haute Autorite de Sante) has recommended that it be administered only to those over the age of 55 – citing a "possible increased risk" of blood clotting in younger people. |
Some European leaders have attempted to relieve concerns about the AstraZeneca vaccine by promising to take it themselves. | Some European leaders have attempted to relieve concerns about the AstraZeneca vaccine by promising to take it themselves. |
Think your friends would be interested? Share this story! | Think your friends would be interested? Share this story! |
Dear readers and commenters, | |
We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
Sorry for the inconvenience, and looking forward to your future comments, | |
RT Team. |